Related Experiment Video
Updated: May 26, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy
Giovanni Quarta1, Petros Syrris, Michael Ashworth
1The Heart Hospital, University College London Hospitals Trust, 16-18 Westmoreland Street, London W1G 8PH, UK.
Insights
Mutations in the Lamin A/C gene (LMNA) are linked to severe arrhythmogenic right ventricular cardiomyopathy (ARVC). Genetic testing for LMNA mutations is recommended for ARVC patients, especially those with conduction abnormalities.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart condition primarily linked to desmosomal gene mutations.
- Lamin A/C gene (LMNA) mutations are known to cause dilated cardiomyopathy, conduction issues, and sudden cardiac death.
Purpose of the Study:
- To investigate the prevalence of LMNA mutations in a large cohort of ARVC patients.
- To determine if LMNA mutations are associated with severe ARVC phenotypes.
Main Methods:
- Genetic screening of 108 ARVC patients for desmosomal genes and LMNA.
- LMNA mutation analysis using standard PCR and direct sequencing.
- Histopathological examination of myocardial tissue from affected patients.
Main Results:
- LMNA mutations were identified in 4% of ARVC patients who did not have desmosomal gene mutations.
- Patients with LMNA mutations exhibited severe right ventricular involvement, conduction abnormalities, and increased mortality.
- Myocardial analysis revealed myocyte loss and fibro-fatty replacement, with reduced plakoglobin staining at intercalated discs.
Conclusions:
- LMNA gene mutations are associated with severe forms of ARVC.
- Genetic testing for LMNA should be included in the workup for suspected ARVC, particularly in patients with ECG-detected conduction disease.
Aims:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease predominantly caused by mutations in desmosomal protein genes. Lamin A/C gene (LMNA) mutations are associated with dilated cardiomyopathy, conduction abnormalities and high incidence of sudden cardiac death. In this study, we screened a large cohort of ARVC patients for LMNA mutations.
Methods And Results:
One hundred and eight patients from unrelated families with borderline (n = 27) or definite (n = 81) diagnosis of ARVC were genetically tested for five desmosomal genes and LMNA. Sixty-one (56.5%) were positive for desmosomal gene mutations. Standard polymerase chain reaction (PCR) amplification of the 12 protein-coding LMNA exons was performed and mutational screening performed by direct sequencing. Four patients (4%) without desmosomal gene mutations carried LMNA variants. Three had severe right ventricular involvement, and during follow-up three died (two suddenly and one from congestive heart failure); all three had conduction abnormalities on resting 12-lead electrocardiogram (ECG). Myocardial tissue from two patients showed myocyte loss and fibro-fatty replacement. In one of these, immunohistochemical staining with antibody to plakoglobin showed reduced/absent staining of the intercalated discs in the myocardium.
Conclusion:
Lamin A/C gene mutations can be found in severe forms of ARVC. Lamin A/C gene should be added to desmosomal genes when genetically testing patients with suspected ARVC, particularly when they also have ECG evidence for conduction disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Mitral Valve Prolapse I: Introduction

